Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: GlaxoSmithKline

HEALTH-CORONAVIRUS/FRANCE-ICU
RTXBZY7A
May 04, 2021
GlaxoSmithKline's (GSK) drug, Augmentin, is seen in the COVID-19 Intensive Care Unit (ICU) at the Centre...
Saint-Denis, France
Intensive care unit at the Centre Cardiologique du Nord private hospital in Saint-Denis near Paris
GlaxoSmithKline's (GSK) drug, Augmentin, is seen in the COVID-19 Intensive Care Unit (ICU) at the Centre Cardiologique du Nord private hospital in Saint-Denis, near Paris, amid the coronavirus disease pandemic in France, May 4, 2021. REUTERS/Benoit Tessier
CHINA-TRADE/EXPO
RTX87CCV
November 05, 2020
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China...
Shanghai, China
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song
CHINA-TRADE/EXPO
RTX87CCX
November 05, 2020
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China...
Shanghai, China
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song
CHINA-TRADE/EXPO
RTX87CCP
November 05, 2020
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China...
Shanghai, China
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song
GSK-RESULTS/
RTX855HV
October 26, 2020
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October...
STEVENAGE, United Kingdom
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs
GSK-RESULTS/
RTX855HN
October 26, 2020
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October...
STEVENAGE, United Kingdom
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs
HEALTH-CORONAVIRUS/USA
RTX7J4WY
May 15, 2020
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the...
Washington, UNITED STATES
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington...
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, speaks as U.S. President Donald Trump listens during a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque
HEALTH-CORONAVIRUS/USA
RTX7J4JL
May 15, 2020
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the...
Washington, UNITED STATES
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington...
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, adjusts his protective face mask after speaking as President Donald Trump holds a coronavirus disease vaccine event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque
HEALTH-CORONAVIRUS/USA
RTX7J4J2
May 15, 2020
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the...
Washington, UNITED STATES
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington...
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, listens while wearing a protective face mask as President Donald Trump holds a coronavirus disease vaccine event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque
HEALTH-CORONAVIRUS/USA
RTX7J4IH
May 15, 2020
U.S. President Donald Trump passes former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who...
Washington, UNITED STATES
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington...
U.S. President Donald Trump passes former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, as he removes his face mask to speak during a coronavirus response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque
HEALTH-CORONAVIRUS/USA
RTX7J4BR
May 15, 2020
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the...
Washington, UNITED STATES
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington...
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, adjusts his protective face mask after speaking as President Donald Trump holds a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque
HEALTH-CORONAVIRUS/USA
RTX7J4BT
May 15, 2020
U.S. President Donald Trump looks on as former GlaxoSmithKline pharmaceutical executive Moncef Slaoui,...
Washington, UNITED STATES
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington...
U.S. President Donald Trump looks on as former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, removes his face mask during a coronavirus response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque
HEALTH-CORONAVIRUS/USA
RTX7J4B8
May 15, 2020
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the...
Washington, UNITED STATES
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington...
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, waits to speak as President Donald Trump holds a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque
HEALTH-CORONAVIRUS/USA
RTX7J4B2
May 15, 2020
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the...
Washington, UNITED STATES
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington...
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, speaks as President Donald Trump listens during a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7U
May 05, 2020
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7M
May 05, 2020
A general view outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
A general view outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville
HEALTH-CORONAVIRUS/BRITAIN-AUTOS
RTX7HC7L
May 05, 2020
A tribute to care workers is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
A tribute to care workers is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7E
May 05, 2020
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville
HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O6
May 04, 2020
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs
HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O4
May 04, 2020
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs
HEALTH-PHARMACY/
RTS2XT0V
January 09, 2020
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy...
Provo, UNITED STATES
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy...
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey
GSK-RESULTS/
RTX7AKVN
November 26, 2019
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline...
STEVENAGE, United Kingdom
A scientist studies cancer cells inside white blood cells through a microscope at the GSK research centre...
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVJ
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVG
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVA
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV9
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV7
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV6
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV5
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV4
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV3
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV2
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV1
November 26, 2019
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUX
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUR
November 26, 2019
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUP
November 26, 2019
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November...
STEVENAGE, United Kingdom
A GSK logo is seen on a flag at a GSK research centre in Stevenage
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKSX
November 26, 2019
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019....
STEVENAGE, United Kingdom
A GSK logo is seen at the GSK research centre in Stevenage
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKSP
November 26, 2019
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019....
STEVENAGE, United Kingdom
A GSK logo is seen at the GSK research centre in Stevenage
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
BRITAIN-EU/
RTX6G1D0
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1CX
October 22, 2018
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool...
MONTROSE, United Kingdom
GlaxoSmithKline's production building is seen in Montrose, Scotland
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1CV
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1CU
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1CG
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1CB
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1C7
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1C5
October 22, 2018
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool...
MONTROSE, United Kingdom
GlaxoSmithKline's production building is seen in Montrose, Scotland
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BZ
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BW
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BU
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BS
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BR
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BP
October 22, 2018
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland,...
MONTROSE, United Kingdom
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland...
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BM
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BK
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BH
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BG
October 22, 2018
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,...
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BD
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BB
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1AQ
October 22, 2018
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool...
MONTROSE, United Kingdom
GlaxoSmithKline's production building is seen in Montrose, Scotland
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1AL
October 22, 2018
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool...
MONTROSE, United Kingdom
GlaxoSmithKline's production building is seen in Montrose, Scotland
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
Sort by
Display
Items per page
Page
of 7